CRON - Cronos Group Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
21.29
+0.47 (+2.26%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close20.82
Open21.46
Bid21.30 x 800
Ask21.32 x 900
Day's Range20.97 - 21.84
52 Week Range5.12 - 25.10
Volume16,070,346
Avg. Volume15,593,333
Market Cap3.794B
Beta (3Y Monthly)4.38
PE Ratio (TTM)N/A
EPS (TTM)-0.03
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Cramer's lightning round: These are the two pot stocks I'm recommending
    CNBC Videos3 days ago

    Cramer's lightning round: These are the two pot stocks I'm recommending

    Jim Cramer rattles off his responses to callers' stock questions, including one on a top cannabis play.

  • Sira Naturals CEO on the cannabis industry
    Yahoo Finance Video4 days ago

    Sira Naturals CEO on the cannabis industry

    Yahoo Finance's Alexis Keenan interviews Michael Dundas, CEO of Sira Naturals, on The Final Round from The Seed to Sale Show in Boston to talk about the latest trends in the cannabis industry.

  • Surprise! The Biggest Marijuana ETF Just Made a Massive Move
    Motley Fool3 hours ago

    Surprise! The Biggest Marijuana ETF Just Made a Massive Move

    Find out what happened -- and how.

  • ACCESSWIRE23 hours ago

    Finding the Next Hot Cannabis Play

    HENDERSON, NV / ACCESSWIRE / February 15, 2019 / With Cannabis companies already having an amazing 2019, we decided to hunt for the next potential breakout candidate. We searched amongst lesser known companies ...

  • 4 Reasons Why Marijuana Stocks & ETFs Could Be on a High in 2019
    Zacks23 hours ago

    4 Reasons Why Marijuana Stocks & ETFs Could Be on a High in 2019

    Marijuana stocks and related ETFs caught investors' attention last year, courtesy of its mysterious rally in mid-2018 on Canada's legalization of recreational marijuana in October. Let's take a look at whether the space will be able to maintain its rally in 2019.

  • Canopy Growth Rises after Earnings Beat
    Market Realistyesterday

    Canopy Growth Rises after Earnings Beat

    Canopy Growth Rises after Earnings BeatCanopy Growth risesCanopy Growth (WEED) (CGC) was trending higher by 5% when markets opened. The company reported its earnings late last evening at around 8:45 PM EST.The company reported strong top-line

  • ACCESSWIREyesterday

    Companies Leading the Cannabis Rally

    HENDERSON, NV / ACCESSWIRE / February 15, 2019 / Cannabis stocks are having an incredible 2019 thus far. The sector appeared to have peaked in the fall of 2018. When Canada's legalization went into effect, ...

  • ACCESSWIREyesterday

    4 Marijuana Stocks to Have on Your Watchlist on Friday (2/15/19)

    Premier Health Group (OTC:PHGRF) (CSE:PHGI), Aphria Inc (APHA), Canopy Growth Corp (CGC), and Cronos Group Inc (CRON) represent four pot stocks looking to close out a strong week. Premier Health Group (OTC:PHGRF) (CSE:PHGI) is unlike many companies in the cannabis sector because its core framework is built around healthcare. The Company is largely focused on meeting the growing challenges of the healthcare industry through investments in advanced telemedical technologies and other innovations.

  • Investing.comyesterday

    Marijuana Stocks Rise After Canopy Growth Sales Surprise

    The medical marijuana firm jumped 3% midday, despite its revenue of $62.35 million missing Investing.com estimates of $66 million.

  • Why Marijuana ETFs are on a High in 2019
    Zacks2 days ago

    Why Marijuana ETFs are on a High in 2019

    After being beaten down in the final quarter of 2018, pot stocks staged a nice comeback at the start of this year on the renewed appeal for riskier assets. Here's why ETFs are riding high this year.

  • ACCESSWIRE2 days ago

    4 Marijuana Stocks Making Moves on News This Week

    Premier Health Group (OTC:PHGRF) (CSE:PHGI), Aurora Cannabis Inc (NYSE: ACB, TSX: ACB), Cronos Group Inc (CRON), and New Age Beverages Corporation (NBEV) represent four cannabis worth keeping on your radar. Premier Health Group (OTC:PHGRF) (CSE:PHGI) is a company determined to meet the challenges of our ever-evolving healthcare system. The Company's subsidiary, HealthVue, currently boasts an ecosystem of over 100,000 active patients and plans to rapidly increase that number both domestically and internationally.

  • ACCESSWIRE2 days ago

    Cannabis Stocks You Can't Afford to Miss

    HENDERSON, NV / ACCESSWIRE / February 14, 2019 / Below are several cannabis companies you do not want to miss the boat on. One in particular is already starting to make its investors serious gains: CleanSpark, ...

  • 4 Best Marijuana Stocks to Play the Green Rush
    Zacks3 days ago

    4 Best Marijuana Stocks to Play the Green Rush

    Whether its eating a gooey, chocolatey brownie or taking a few hits off a freshly rolled joint, it???s common knowledge that a lot of people like to get high. Many investors, however, have yet to "light up." What are the best marijuana stocks out there right now?

  • Aurora Cannabis is a prime example of why marijuana investors should focus on money flows
    MarketWatch3 days ago

    Aurora Cannabis is a prime example of why marijuana investors should focus on money flows

    With Aurora Cannabis and most other marijuana stocks, sentiment and short squeezes are directing price action.

  • Benzinga3 days ago

    KushCo, DionyMed And More Investor Presentations From The Cannabis Capital Conference

    The 2019 Benzinga Cannabis Capital Conference in Miami Beach included investor presentations from KushCo, Medicine Man and other major companies in the space. California-based Kushco, which began as a packaging company, is primarily focused on being as much of a business-to-business company as possible, Christoffersen said.

  • Barrons.com3 days ago

    Pot Stocks Go Higher on Hopes for Banking Reform

    Marijuana companies are hoping for banking reform that will allow them to switch from being cash-only businesses.

  • InvestorPlace3 days ago

    An Unexpected Danger Could Smoke Philip Morris Stock

    For the fourth consecutive quarter, Philip Morris (NYSE:PM) beat earnings estimates. The New York-based international tobacco company reported higher-than-expected numbers on both the top and bottom lines. Although both profits and revenue fell on a year-over-year basis, investors reacted well to the news, bidding PM stock higher each of the following two days. * 7 Forever Stocks to Buy for Long-Term Gains However, with its high dividend, most investors focus on the payout. The generous yield, along with the 11-year streak of increases, has drawn investors into Philip Morris stock since the beginning. However, investors may want to approach PM stock dividend cautiously, as it faces an unexpected danger. Earnings, Revenue Beat Boosted PM StockFor the fourth quarter, the company reported non-GAAP earnings of $1.25 per share. This came in eight cents ahead of analyst expectations. Despite the higher-than-expected earnings, it still represents a year-over-year drop as PM earned $1.32 per share in the same quarter last year. Revenues of $7.5 billion also beat estimates by $110 million. Still, they fell by 9.5% from last year's $8.29 billion in the year-ago quarter.InvestorPlace - Stock Market News, Stock Advice & Trading TipsInvestors took the news well as PM stock rose by about 1.6% in Thursday trading. It increased by an additional 4.2% on Friday.Much like its former parent Altria (NYSE:MO), PM stock has dealt with the poor reputation and the marginalization of its core product. However, PM tends to maintain its profit growth. The company has also introduced IQOS, a "heat, not burn" smokeless product. It plans to ultimately replace cigarettes with IQOS in the coming years and that may boost profits as well.PM has also maintained steady growth is in its dividend. The company has increased the payout every year since its split off from Altria in 2008. The annual payout for this year will amount to $4.56 per share. This gives today's buyer a yield of about 5.7%.The PM stock price has grown by only 150% of its value since the March 2009 low. Since this significantly lags the 345% increase seen in the S&P 500 over the same period, most stockholders own PM for its dividend. Here investors need to exercise caution. Beware the Payout RatioActivists have long targeted tobacco and have increasingly disliked PM's smokeless alternative. However, the most immediate danger to PM does not lie there. The near-term threat with PM stock lies in its dividend payout ratio -- the percentage of net income paid out in dividends.The dividend payout ratio has risen to over 85%. Consumer defensive issues like Philip Morris stock tend to maintain higher payout ratios. However, even in PM's sector, they typically remain well under 85%. The company's reduced profit should cause concern. If that pace were to continue, PM could place itself in a position where it pays out more in dividends than it earns.Fortunately, analysts believe it can avert this fate. Wall Street forecasts an average growth rate of about 6% per year over the next five years. Alternative lines of business also remain an option. IQOS receives most of the attention in that area. Also, much like Altria invested in Cronos (NASDAQ:CRON), it could enter the cannabis sector. Philip Morris has so far given no indication it has such plans.Still, unless PM sees higher levels of profit growth, dividend growth should remain a major concern. If Philip Morris reports lower revenues and profits, I would recommend getting out before the inevitable dividend cut. The Bottom Line on PM StockThe dividend payout ratio on PM stock poses a more immediate threat to the equity than the reputation of its core product. Philip Morris continues to earn profits. However, the company reported lower profits than last year. This creates a precarious situation, as the company tends to increase its dividend annually and pay out nearly all of its profits in the form of dividends. Any interruption to these increases will devastate PM stock. * 12 2018 Winners That Will Be Big Ol' Losers in 2019 For now, analysts expect profit growth to resume. It has invested heavily in its smokeless product and, like its U.S.-focused counterpart, it could also enter the cannabis market. However, profit growth has become paramount. If profits continue to fall, investors need to smoke PM stock out.As of this writing, Will Healy did not hold a position in any of the aforementioned stocks. You can follow Will on Twitter at @HealyWriting. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks That Every 20-Year-Old Should Buy * 10 Best Dividend Stocks to Buy for the Next 10 Months * 10 Monster Growth Stocks to Buy for 2019 and Beyond Compare Brokers The post An Unexpected Danger Could Smoke Philip Morris Stock appeared first on InvestorPlace.

  • Digging Deep into Altria’s Investment in JUUL Labs
    Market Realist4 days ago

    Digging Deep into Altria’s Investment in JUUL Labs

    Why Altria Is Betting Big on JUUL Labs and Cronos Group(Continued from Prior Part)Altria’s investment On December 20, Altria Group (MO) announced a $12.8 billion investment in JUUL Labs for a 35% stake in the e-cigarette company. According to the

  • Is Aurora Cannabis Stock Worth a Buy on Stratospheric Sales?
    InvestorPlace4 days ago

    Is Aurora Cannabis Stock Worth a Buy on Stratospheric Sales?

    Aurora Cannabis (NYSE:ACB) has been a rocket this year, with Aurora Cannabis stock spiking about 44%. But things got off to a rocky start this week when the shares dropped by 5%. The main concern for ACB stock investors? The upcoming earnings report. Although the stock has since recovered some of the losses, it's still worth a deeper look into their concerns. Click to Enlarge Source: Shutterstock So let's take a look at the fiscal second-quarter results.Revenue came close to quadrupling to C$54.2 million (in Canadian dollars), while the Street was looking for C$51.84 million (although, there are only two analysts with estimates). Last month, ACB issued its own forecast, which called for the top-line to range from C$50 million and C$55 million.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThis hyper-growth should be no surprise. In October, the Canadian government legalized cannabis for recreational purposes. While there were supply issues and other snafus, the demand was off-the-charts. Note that ACB generated C$21.6 million from the consumer category in the quarter. This came to roughly 20% of marketshare.However, ACB's bottom line was far from inspiring. The company posted a massive loss of C$237.8 million, which was mostly due to charges from investments in cannabis companies. Keep in mind that the company is required to make adjustments to changes in market values.There was also deterioration in gross margins, which is probably the biggest factor impacting Aurora Cannabis stock. They plunged from 70% to 54% on a quarter-over-quarter basis. * 10 Stocks That Every 20-Year-Old Should Buy But on the earnings call, CFO Glen Ibbott noted that the company should be able to reach EBITDA positive by fiscal Q4. He also showed that the company has been disciplined with operating costs. And yes, there should be a big help from surging revenues and improvements in the production process.In the meantime, the medical business continues to get traction. There are currently over 73,000 patients in Canada and ACB is conducting 40 clinical trials and seven pre-clinical studies. Even just a few drug launches could have a major impact on revenues.All this means that high-quality production at scale is critical. To this end, ACB is running at annual production of about 120,000 kilograms and this is expected to increase by 30,000 within a month or so. Bottom Line on Aurora Cannabis StockACB stock is far from cheap. Consider that the market cap is at a hefty $7.3 billion. But then again, the rest of the sector is trading at premium valuations, as seen with Canopy Growth (NYSE:CGC), Tilray (NASDAQ:TLRY) and Cronos Group (NASDAQ:CRON).But this is to be expected because of the massive growth opportunities in the sector. According to Altria (NYSE:MO) CEO Howard Willard, the spending on cannabis is expected to reach $40 billion within the next ten years on a global basis. As a testament to his enthusiasm for the sector, he recently invested $1.8 billion in CRON.As for ACB, it has leveraged its highly valued stock to pull off aggressive M&A. This has allowed the company to gain important footholds in areas like Europe and South America (there is now a presence in 22 countries across five continents). ACB also has been able to assemble a large retail business in Canada.Now as for Aurora Cannabis stock, there will be continued volatility. This is normal for any high-growth company. Besides, the business is diversified, well funded (with a recent convertible note offering of $345 million) and the M&A strategy looks spot on. In other words, for those looking for a play on cannabis, ACB stock is a pretty good choice.Tom Taulli is the author of High-Profit IPO Strategies, All About Commodities and All About Short Selling. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks That Every 20-Year-Old Should Buy * 10 Best Dividend Stocks to Buy for the Next 10 Months * 10 Monster Growth Stocks to Buy for 2019 and Beyond Compare Brokers The post Is Aurora Cannabis Stock Worth a Buy on Stratospheric Sales? appeared first on InvestorPlace.

  • Aurora Cannabis Provides Updates on Hemp and Softgel Format in Q2
    Market Realist4 days ago

    Aurora Cannabis Provides Updates on Hemp and Softgel Format in Q2

    Aurora Cannabis Provides Updates on Hemp and Softgel Format in Q2Hemp update Aurora Cannabis (ACB) reported its earnings yesterday and provided some key insights into its hemp business activity. On its earnings call, Aurora Cannabis stated that its

  • Aurora Cannabis: Key Takeaways from Its Q2 Earnings
    Market Realist4 days ago

    Aurora Cannabis: Key Takeaways from Its Q2 Earnings

    Aurora Cannabis: Key Takeaways from Its Q2 EarningsSecond-quarter earningsOn February 11, Aurora Cannabis (ACB) reported its second-quarter earnings after the market closed. The company beat the top-line (revenue) estimates but missed the

  • ACCESSWIRE4 days ago

    Biotech Plays in the News You Should Know

    HENDERSON, NV / ACCESSWIRE / February 12, 2019 / Below are several companies in the biotech space that are making news and drawing investor interest. These companies have the potential to make investors ...

  • Pot Stocks: Who Has the Best Earnings Chart?
    Zacks4 days ago

    Pot Stocks: Who Has the Best Earnings Chart?

    Pot stocks are entering the investing mainstream but do they have what it takes to compete against mature industries?

  • GlobeNewswire4 days ago

    New Research: Key Drivers of Growth for Cronos Group, Spectrum Brands, Black Hills, Entercom Communications, CSS Industries, and Syndax Pharmaceuticals — Factors of Influence, Major Initiatives and Sustained Production

    NEW YORK, Feb. 12, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • How to tell when a marijuana-stock rally is real or a mirage
    MarketWatch5 days ago

    How to tell when a marijuana-stock rally is real or a mirage

    As marijuana stocks have rallied recently, many investors have gotten in over their heads. For both groups, investors are forgetting that marijuana stocks can be volatile. When I wrote “How to potentially become a marijuana millionaire, albeit carefully,” the most important word in the headline was “carefully.” Some will gain, but many more will lose.